Published in Br J Pharmacol on November 01, 1985
Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol (1985) 2.37
Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br J Pharmacol (1985) 1.48
Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach. Br J Pharmacol (1985) 1.42
Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach. Br J Pharmacol (1985) 1.23
Correlation between log POCT/H2O and pKB estimates for a series of muscarinic and histamine H2-receptor antagonists. Br J Pharmacol (1988) 1.18
Activation of multiple sites by adenosine analogues in the rat isolated aorta. Br J Pharmacol (1996) 1.04
Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action. Br J Pharmacol (1992) 1.01
Pharmacological analysis of the inhibition by pirenzepine and atropine of vagal-stimulated acid secretion in the isolated stomach of the mouse. Br J Pharmacol (1986) 0.97
2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist. Br J Pharmacol (1993) 0.96
Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder. Br J Pharmacol (1992) 0.95
Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline. J Physiol (1990) 0.90
Direct block of native and cloned (Kir2.1) inward rectifier K+ channels by chloroethylclonidine. Br J Pharmacol (1999) 0.88
The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat. Br J Pharmacol (1991) 0.88
Histamine dependence of pentagastrin-stimulated gastric acid secretion in rats. Yale J Biol Med (1994) 0.87
Comparative analysis of the vagal stimulation of gastric acid secretion in rodent isolated stomach preparations. Br J Pharmacol (1994) 0.85
Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells. Br J Pharmacol (1999) 0.85
Pharmacological analysis of the interaction between purinoceptor agonists and antagonists in the guinea-pig taenia caecum. Br J Pharmacol (1995) 0.85
Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Br J Pharmacol (1996) 0.83
Comparative study of the control of basal acid output from rodent isolated stomachs. Br J Pharmacol (1993) 0.81
Benzamil sensitive ion channels contribute to volume regulation in canine chondrocytes. Br J Pharmacol (2013) 0.80
Inhibition by alpha-tetrahydrodeoxycorticosterone (THDOC) of pre-sympathetic parvocellular neurones in the paraventricular nucleus of rat hypothalamus. Br J Pharmacol (2006) 0.80
Application of a model to explore interspecies differences in acetylcholine M-receptor-stimulated gastric acid secretion. Br J Pharmacol (1995) 0.79
Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat. Br J Pharmacol (1996) 0.79
Negative inotropic effects of isoprenaline on isolated left atrial assays from aged transgenic mice with cardiac over-expression of human beta(2)-adrenoceptors. Br J Pharmacol (2000) 0.79
The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle. Br J Pharmacol (1995) 0.78
Differential effects of Na+, K(+)-ATPase inhibition by ouabain on acid secretory responses to histamine and bethanechol in the mouse isolated stomach. Br J Pharmacol (1994) 0.75
Proceedings of the British Pharmacological Society. Cambridge, 8th-10th April 1987. Abstracts. Br J Pharmacol (1987) 0.75
Fade and tachyphylaxis of gastric acid secretory response to pentagastrin in rat isolated gastric mucosa. Br J Pharmacol (1988) 0.75
Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig. Br J Pharmacol (1988) 0.75
The role of platelet activating factor in allergic respiratory disease. Br J Clin Pharmacol (1990) 0.75
Pharmacology: analysis and exploration. Br Med J (Clin Res Ed) (1986) 0.75
Lack of cholinergic innervation in gastric mucosa does not affect gastrin secretion or basal acid output in neurturin receptor GFRα2 deficient mice. J Physiol (2013) 0.75
Some statistical methods useful in circulation research. Circ Res (1980) 11.88
Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. Gastroenterology (1974) 2.87
Histamine and gastric secretion: a later look, 1955-1965. Fed Proc (1966) 2.50
ICI 125,211: a new gastric antisecretory agent acting on histamine H2-receptors. Life Sci (1979) 2.17
Metiamide and stimulated acid secretion from the isolated non-distended and distended mouse stomach. J Physiol (1977) 2.09
Effects of secretagogues on oxygen consumption, aminopyrine accumulation and morphology in isolated gastric glands. Acta Physiol Scand (1976) 1.97
Secretagogue stimulation of [14C]aminopyrine accumulation by isolated canine parietal cells. Am J Physiol (1980) 1.88
Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br J Pharmacol (1985) 1.48
Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay. Br J Pharmacol (1980) 1.45
Histamine-stimulated hydrogen ion secretion by in vitro piglet gastric mucosa. J Physiol (1975) 1.44
Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach. Br J Pharmacol (1985) 1.42
Effect of metiamide on acid secretion from isolated kitten fundic mucosa. Can J Physiol Pharmacol (1975) 1.36
Characterization of an adenylate cyclase system sensitive to histamine H2-receptor excitation in cells from dog gastric mucosa. Agents Actions (1976) 1.34
Histamine: entering physiology. Experientia (1972) 1.27
Conditions affecting acid secretion by mouse stomachs in vitro. Gastroenterology (1950) 1.26
The interaction of choline esters, vagal stimulation and H2-receptor blockade on acid secretion in vitro. Eur J Pharmacol (1982) 1.20
Cholinergic pathway of gastric acid secretion in the isolated whole stomach of the mouse. Pharmacology (1980) 1.17
Gastric secretion in the isolated stomach of the guinea-pig. J Physiol (1974) 1.06
Studies on the actions and interactions of secretagogues on isolated mammalian parietal cells as reflected in changes in oxygen consumption and aminopyrine uptake. Gastroenterology (1977) 1.03
Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man. Gut (1975) 1.03
Inhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles. Br J Pharmacol (1984) 1.03
The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch. Agents Actions (1981) 1.00
Studies on gastric acid secretion using an isolated whole mammalian stomach in vitro. J Physiol (1975) 1.00
Ultrastructural localisation of carbonic anhydrase in rat stomach parietal cells. Histochemie (1970) 0.92
Analysis of the dose-response relationship of histamine and N tau-methylhistamine. Agents Actions (1982) 0.86
Definition and antagonism of histamine H 2 -receptors. Nature (1972) 18.58
Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci (1983) 6.89
Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions (1973) 6.82
Comparison of some properties of pronethalol and propranolol. Br J Pharmacol Chemother (1965) 4.71
An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. Br J Pharmacol (1975) 2.91
International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev (1997) 2.71
An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol (1985) 2.68
Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay. Br J Pharmacol (1985) 2.37
Breast disease: dynamic spiral MR imaging. Radiology (1998) 1.89
Analysis of anomalous pKb values for metiamide and atropine in the isolated stomach of the mouse. Br J Pharmacol (1979) 1.78
Production of acid secretion in the mouse isolated stomach by electrical field stimulation [proceedings]. Br J Pharmacol (1978) 1.54
Effects in man of histamine H 2 -receptor blockade by burimamide. Lancet (1972) 1.51
The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Pharmacol (1975) 1.51
The pharmacological classification of practolol and chloropractolol. Mol Pharmacol (1978) 1.49
Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach. Br J Pharmacol (1985) 1.48
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev (1995) 1.45
Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay. Br J Pharmacol (1980) 1.45
Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach. Br J Pharmacol (1985) 1.42
Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach. Br J Pharmacol (1985) 1.23
Humoral immune response to the bovine immunodeficiency-like virus in experimentally and naturally infected cattle. J Virol (1990) 1.22
Pathogenic differences between various feline coronavirus isolates. Adv Exp Med Biol (1984) 1.21
Inotropic "A" ring substituted sulmazole and isomazole analogues. J Med Chem (1990) 1.21
The interaction of choline esters, vagal stimulation and H2-receptor blockade on acid secretion in vitro. Eur J Pharmacol (1982) 1.20
Correlation between log POCT/H2O and pKB estimates for a series of muscarinic and histamine H2-receptor antagonists. Br J Pharmacol (1988) 1.18
Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am J Vet Res (1983) 1.14
Comparative assay of histamine H2-receptor antagonists using the isolated mouse stomach [proceedings]. Br J Pharmacol (1978) 1.13
Idiopathic pulmonary haemosiderosis with myocarditis. Radio-isotope studies in a patient treated with prednisone. Thorax (1966) 1.11
Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant. Br J Pharmacol (1986) 1.09
Respiratory failure precipitated by high carbohydrate loads. Ann Intern Med (1981) 1.08
Cardiac-specific overexpression of human beta2 adrenoceptors in mice exposes coupling to both Gs and Gi proteins. Br J Pharmacol (2003) 1.06
Characterization of a new calicivirus isolated from feces of a dog. Arch Virol (1985) 1.04
Antagonism of an indirectly acting agonist: block by propranolol and sotalol of the action of tyramine on rat heart. Eur J Pharmacol (1980) 1.04
Proceedings: Effects of dibutyryl cyclic AMP and phosphodiesterase inhibitors on acid secretion by mouse stomach in vitro. Br J Pharmacol (1976) 1.04
Plaque assay, polypeptide composition and immunochemistry of feline infectious peritonitis virus and feline enteric coronavirus isolates. Adv Exp Med Biol (1984) 1.03
Are gastrin receptors located on parietal cells [proceedings]? Br J Pharmacol (1977) 1.02
Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action. Br J Pharmacol (1992) 1.01
Recovery and in vitro cultivation of a coronavirus from laboratory-induced cases of feline infectious peritonitis (FIP). Vet Med Small Anim Clin (1980) 0.99
Pharmacological analysis of beta-adrenoceptor-mediated agonism in the guinea-pig, isolated, right atrium. Br J Pharmacol (1985) 0.98
Pharmacological analysis of the inhibition by pirenzepine and atropine of vagal-stimulated acid secretion in the isolated stomach of the mouse. Br J Pharmacol (1986) 0.97
Parvoviral enteritis and panleukopenia in dogs. Vet Med Small Anim Clin (1979) 0.96
2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist. Br J Pharmacol (1993) 0.96
Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder. Br J Pharmacol (1992) 0.95
Analysis of the interaction between histamine H2-receptor antagonists and pentagastrin [proceedings]. Agents Actions (1978) 0.95
Sulphur-methylene isosterism in the development of metiamide, a new histamine H2-receptor antagonist. Nature (1974) 0.95
Breast lesion localization: a freehand, interactive MR imaging-guided technique. Radiology (1998) 0.93
An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle. Br J Pharmacol (2000) 0.92
TiPS on identity. Trends Pharmacol Sci (1996) 0.91
Pharmacological analysis of agonist-antagonist interactions at acetylcholine muscarinic receptors in a new urinary bladder assay. Br J Pharmacol (1991) 0.90
Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta. Br J Pharmacol (1996) 0.88
Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists. J Med Chem (2000) 0.88
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development. Regul Pept (2010) 0.88
Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle. Br J Pharmacol (2002) 0.88
Histamine dependence of pentagastrin-stimulated gastric acid secretion in rats. Yale J Biol Med (1994) 0.87
Interpretation of agonist affinity estimations: the question of distributed receptor states. Proc R Soc Lond B Biol Sci (1990) 0.86
Can chloropractolol alkylate beta adrenoceptors? Nature (1977) 0.85
Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes. Br J Pharmacol (1999) 0.85
Activation and blockade of beta adrenoceptors in common cardiac disorders. Br Med Bull (1973) 0.85
Comparative analysis of the vagal stimulation of gastric acid secretion in rodent isolated stomach preparations. Br J Pharmacol (1994) 0.85
Pharmacological analysis of the interaction between purinoceptor agonists and antagonists in the guinea-pig taenia caecum. Br J Pharmacol (1995) 0.85
Analysis of the effects of alpha 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery. Br J Pharmacol (1996) 0.85
Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex. Br J Pharmacol (1999) 0.84
Pharmacological classification of adenosine receptors in the sinoatrial and atrioventricular nodes of the guinea-pig. Br J Pharmacol (1998) 0.84
Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries. Br J Pharmacol (1995) 0.84
Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Br J Pharmacol (1996) 0.83
Pharmacological characterization of cholecystokinin receptors mediating contraction of human gallbladder and ascending colon. Regul Pept (2002) 0.83
Analysis of variation in L-365,260 competition curves in radioligand binding assays. Br J Pharmacol (1996) 0.83
Resultant action of cimetidine in a cardiac adenylate cyclase assay: its elucidation by concentration-ratios analysis. J Pharmacol Exp Ther (1987) 0.82
Detection of a cell line contaminated with hog cholera virus. J Am Vet Med Assoc (1994) 0.82
Ahlquist and the development of beta-adrenoceptor antagonists. Postgrad Med J (1976) 0.82
The magnitude of pitch inflection. Arch Psicol Neurol Psichiatr (1970) 0.81
Comparative study of the control of basal acid output from rodent isolated stomachs. Br J Pharmacol (1993) 0.81
Can clinically relevant histamine release be accurately diagnosed in anaesthetised patients without plasma histamine measurements? Randomised study with nested sampling aimed to change paradigms. Inflamm Res (1998) 0.81
Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists. J Med Chem (2000) 0.81
Subsensitivity to epinephrine following the administration of epinephrine and ephedrine to normal individuals. J Allergy Clin Immunol (1975) 0.81
Clinical experience with metiamide. Fed Proc (1976) 0.80
Evidence that histamine homologues discriminate between H3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus. Br J Pharmacol (1999) 0.80